Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial

被引:13
|
作者
Vos-Vromans, Desiree [1 ]
Evers, Silvia [2 ,3 ]
Huijnen, Ivan [4 ,5 ,6 ]
Koke, Albere [6 ]
Hitters, Minou [7 ]
Rijnders, Nieke [1 ]
Pont, Menno [8 ]
Knottnerus, Andre [9 ]
Smeets, Rob [4 ,5 ,7 ]
机构
[1] Revant Rehabil Ctr, Breda, Netherlands
[2] Maastricht Univ, Res Sch CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands
[3] Natl Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands
[4] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Maastricht, Netherlands
[5] Acad Hosp Maastricht, Dept Rehabil Med, Maastricht, Netherlands
[6] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands
[7] Libra Rehabil & Audiol, Eindhoven, Netherlands
[8] Reade Ctr Rheumatol & Rehabil, Amsterdam, Netherlands
[9] Maastricht Univ, Res Sch CAPHRI, Dept Gen Practice, Maastricht, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
HEALTH-CARE DECISIONS; QUALITY-OF-LIFE; COST-EFFECTIVENESS; MULTIPLE-SCLEROSIS; DETERMINE WHETHER; HRQOL MEASURE; PROGRAM; POPULATIONS; MANAGEMENT; VALIDITY;
D O I
10.1371/journal.pone.0177260
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background A multi-centre RCT has shown that multidisciplinary rehabilitation treatment (MRT) is more effective in reducing fatigue over the long-term in comparison with cognitive behavioural therapy (CBT) for patients with chronic fatigue syndrome (CFS), but evidence on its costeffectiveness is lacking. Aim To compare the cost-effectiveness of MRT versus CBT for patients with CFS from a societal perspective. Methods A multi-centre randomized controlled trial comparing MRT with CBT was conducted among 122 patients with CFS diagnosed using the 1994 criteria of the Centers for Disease Control and Prevention and aged between 18 and 60 years. The societal costs (healthcare costs, patient and family costs, and costs for loss of productivity), fatigue severity, quality of life, quality-adjusted life-year (QALY), and cost-effectiveness ratios (ICERs) were measured over a follow-up period of one year. The main outcome of the cost-effectiveness analysis was fatigue measured by the Checklist Individual Strength (CIS). The main outcome of the cost-utility analysis was the QALY based on the EuroQol-5D-3L utilities. Sensitivity analyseswere performed, and uncertainty was calculated using the cost-effectiveness acceptability curves and cost-effectiveness planes. Results The data of 109 patients (57 MRT and 52 CBT) were analyzed. MRT was significantly more effective in reducing fatigue at 52 weeks. The mean difference in QALY between the treatments was not significant (0.09, 95% CI: -0.02 to 0.19). The total societal costs were significantly higher for patients allocated to MRT (a difference of 5,389, 95% CI: 2,488 to 8,091). MRT has a high probability of being the most cost effective, using fatigue as the primary outcome. The ICER is 856 per unit of the CIS fatigue subscale. The results of the cost-utility analysis, using the QALY, indicate that the CBT had a higher likelihood of being more costeffective. Conclusions The probability of being more cost-effective is higher for MRT when using fatigue as primary outcome variable. Using QALY as the primary outcome, CBT has the highest probability of being more cost-effective.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Randomised Controlled Trial of Cognitive Behaviour Therapy Delivered in Groups of Patients with Chronic Fatigue Syndrome
    Wiborg, Jan F.
    van Bussel, Jose
    van Dijk, Agaat
    Bleijenberg, Gijs
    Knoop, Hans
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 (06) : 368 - 376
  • [22] A preliminary, controlled trial of circadian interventions, delivered within a cognitive behavioural framework, in patients with Chronic Fatigue Syndrome
    Tooley, GA
    McCabe, MP
    AUSTRALIAN JOURNAL OF PSYCHOLOGY, 2001, 53 : 178 - 178
  • [23] Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial
    Kikuchi, Shino
    Oe, Yuki
    Sasaki, Yohei
    Ishii, Hirono
    Ito, Yuri
    Horikoshi, Masaru
    Sozu, Takashi
    Seno, Hiroshi
    Furukawa, Toshi A.
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [24] A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome
    Olson, LG
    Ambrogetti, A
    Sutherland, DC
    PSYCHOSOMATICS, 2003, 44 (01) : 38 - 43
  • [25] Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial
    Shino Kikuchi
    Yuki Oe
    Yohei Sasaki
    Hirono Ishii
    Yuri Ito
    Masaru Horikoshi
    Takashi Sozu
    Hiroshi Seno
    Toshi A. Furukawa
    BMC Gastroenterology, 20
  • [26] The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia - A randomized controlled trial
    Lemstra, M
    Olszynski, WP
    CLINICAL JOURNAL OF PAIN, 2005, 21 (02): : 166 - 174
  • [27] Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial
    Stulemeijer, M
    de Jong, LWAM
    Fiselier, TJW
    Hoogveld, SWB
    Bleijenberg, G
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7481): : 14 - 17
  • [28] Cognitive Behavioural Therapy for Chronic Fatigue Syndrome A Guide For Clinicians
    Padfield, Beverley
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2008, 15 (07): : 322 - 322
  • [29] Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial
    Prins, JB
    Bleijenberg, G
    Bazelmans, E
    Elving, LD
    de Boo, TM
    Severens, JL
    van der Wilt, GJ
    Spinhoven, P
    van der Meer, JWM
    LANCET, 2001, 357 (9259): : 841 - 847
  • [30] Economic evaluation of a tailored therapist-guided internet-based cognitive behavioural treatment for patients with psoriasis: a randomized controlled trial
    van Beugen, S.
    Ferwerda, M.
    van Middendorp, H.
    Smit, J. V.
    Zeeuwen-Franssen, M. E. J.
    Kroft, E. B. M.
    de Jong, E. M. G. J.
    van de Kerkhof, P. C. M.
    Kievit, W.
    Evers, A. W. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 614 - 616